Top Cited Articles
Acceptance rate:
12%
Time to first decision with review:
24 days*
Impact Factor (JCR):
24.5
Impact Factor rank (JCR):
5/93
Citescore:
47.4
Total Altmetric mentions:
15,976
Gut microbiome and health: mechanistic insights
Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19
Gut microbiota-derived metabolites as central regulators in metabolic disorders
Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites
Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report
Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome
MicroRNAs as regulators, biomarkers and therapeutic targets in liver diseases
Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort
Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis
Gut microbiome stability and resilience: elucidating the response to perturbations in order to modulate gut health
Long-term dietary patterns are associated with pro-inflammatory and anti-inflammatory features of the gut microbiome
Ginseng polysaccharides alter the gut microbiota and kynurenine/tryptophan ratio, potentiating the antitumour effect of antiprogrammed cell death 1/programmed cell death ligand 1 (anti-PD-1/PD-L1) immunotherapy
Depicting SARS-CoV-2 faecal viral activity in association with gut microbiota composition in patients with COVID-19
Diet quality and risk and severity of COVID-19: a prospective cohort study
Gut microbiota regulate Alzheimer's disease pathologies and cognitive disorders via PUFA-associated neuroinflammation
Cancer pharmacomicrobiomics: targeting microbiota to optimise cancer therapy outcomes
Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBD
Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals
Lactobacillus gallinarum modulates the gut microbiota and produces anti-cancer metabolites to protect against colorectal tumourigenesis
Immunotherapy for advanced hepatocellular carcinoma: a focus on special subgroups